Characteristics of an overdose prevention, response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania. - Wikidata - awgldk - TriplyDB

Characteristics of an overdose prevention, response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania.

Characteristics of an overdose prevention, response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania.

http://www.wikidata.org/entity/Q35597413

about

Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis Application of human factors engineering (HFE) to the design of a naloxone auto-injector for the treatment of opioid emergencies.Circumstances surrounding non-fatal opioid overdoses attended by ambulance services A quantitative and qualitative evaluation of the British Columbia Take Home Naloxone program.Coverage of overdose prevention programs for opiate users and injectors: a cross-sectional study High risk and little knowledge: overdose experiences and knowledge among young adult nonmedical prescription opioid users Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study.A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program.Injection drug users trained by overdose prevention programs: responses to witnessed overdoses.Personal social network factors associated with overdose prevention training participation Predictors of seeking emergency medical help during overdose events in a provincial naloxone distribution programme: a retrospective analysis.Opioid and other substance misuse, overdose risk, and the potential for prevention among a sample of OEF/OIF veterans in New York City.Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists.Evaluating the impact of a national naloxone programme on ambulance attendance at overdose incidents: a controlled time-series analysis."I felt like a superhero": the experience of responding to drug overdose among individuals trained in overdose prevention.Novel interventions to prevent HIV and HCV among persons who inject drugs.Opioid-Involved Overdose Among Male Afghanistan/Iraq-Era U.S. Military Veterans: A Multidimensional Perspective.Treating Addictions: Harm Reduction in Clinical Care and Prevention.Evaluation of knowledge and confidence following opioid overdose prevention training: A comparison of types of training participants and naloxone administration methods.Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia.The economic burden of opioid-related poisoning in the United States.Development of a proto-typology of opiate overdose onset.Incorporation of poison center services in a state-wide overdose education and naloxone distribution program.Emergency Department-based Opioid Harm Reduction: Moving Physicians From Willing to Doing.Expanding access to naloxone in the United States.Intranasal naloxone and related strategies for opioid overdose intervention by nonmedical personnel: a review.Comments and Suggestions from Pain Specialists Regarding the CDC's Proposed Opioid Guidelines.Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: A pilot randomized controlled trial.Recent Overdose Experiences in a Community Sample of Military Veterans Who Use Opioids.Why are some people who have received overdose education and naloxone reticent to call Emergency Medical Services in the event of overdose?Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal.Naloxone dosage for opioid reversal: current evidence and clinical implications.Recurring Epidemics of Pharmaceutical Drug Abuse in America: Time for an All-Drug Strategy.Lay responder naloxone access and Good Samaritan law compliance: postcard survey results from 20 Indiana counties.The Epidemic as Stigma: The Bioethics of Opioids

P2860

Q28075931-E629B2DD-B199-414B-8E89-8741A95CC868 Q28397248-861317C6-4467-4EBD-97FB-0C97FA2F99E1 Q28468357-5AE03097-9B24-4B84-9390-6BA71266756A Q33697978-32E1B09E-B061-489C-AB44-54C8C4DBE06C Q34280151-CEF89AFC-8C03-4FE1-B9F4-150C88FBB472 Q34587153-13778021-7E20-4A4E-9124-CC9746435F9B Q34778050-960781F1-57C8-456A-955B-2CF59E634F7A Q35135608-4FFA72AF-EA7D-40F7-961E-B9BB250F0283 Q35751870-94577E38-02E1-4B61-AD3C-9D2BFFE7C260 Q35855231-0CB98FDF-E981-4B56-9529-4E3648DD90AB Q36451555-2E632C0A-01C6-4548-B2A5-44FE0CD0C91B Q36974799-E8AE09AF-DFF6-4859-874B-D988B2E1DAF7 Q37027821-493D4D7B-5EFA-48EF-93C8-A214AC1A1E62 Q37212102-5109E86C-9211-495E-8125-8261810B3535 Q37309608-FBA6D3B6-5B32-4691-867C-CCB69F2328C7 Q37595941-DCA4B936-490F-4052-9AB3-0850A81E2DE5 Q37625050-FCD12A35-ECA5-4D06-B15F-A058125D0A80 Q38318678-4ED2E698-D847-4913-8ACC-983C4EE60D4D Q38722413-002B83FC-619E-467B-A28B-501A1721A821 Q38817024-976150D0-1E01-47BF-9BE6-D8236D5011C2 Q38948561-6C5D46D3-9488-473F-9390-F7A70DA19945 Q38978228-7EDD9A38-6590-433E-A2D1-A82C3B940A78 Q39387412-11541AAB-354D-4C13-9B94-8D67DEC9E7BA Q39472816-7A9BCEFB-6D8C-463E-9C6A-54936392D9EE Q39740001-0A24CBA0-A1A5-44F3-88A3-56BC60B2A158 Q40055225-11BCD9B2-E9DA-4B3E-9EE5-59CC7CE80894 Q41982971-7B394353-5935-4087-9337-00C40A559349 Q42687927-44B9424A-72FE-4362-BCB6-D4DBA46F462A Q43576588-1871180D-3F50-4FE9-9E15-1441E09DB12B Q44137641-5747411B-D706-4E46-A362-73C06A61F50B Q45326281-7F846F08-BBA6-4A78-9D67-3A3A5CEE65A5 Q47201698-CA918F2D-ACB4-4890-8E31-B62C18FB0217 Q48178385-8218DA1A-61BE-4860-B15C-2CE34FB684D0 Q48275689-3F060DDB-E2C9-472F-8642-B8F397EC7467 Q51820010-865AA43F-BC1A-47E4-B3D1-5BA906FB1A71 Q53416480-5BD822FB-4C20-4068-A054-6AE4E996E6EB Q57897309-6C156C1D-F2C7-4E24-A614-023906CB0A3C

P2860

Characteristics of an overdose prevention, response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania.

http://www.wikidata.org/entity/Q35597413

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Characteristics of an overdose ...... llegheny County, Pennsylvania.

@ast

Characteristics of an overdose ...... llegheny County, Pennsylvania.

@en

type

label

Characteristics of an overdose ...... llegheny County, Pennsylvania.

@ast

Characteristics of an overdose ...... llegheny County, Pennsylvania.

@en

prefLabel

Characteristics of an overdose ...... llegheny County, Pennsylvania.

@ast

Characteristics of an overdose ...... llegheny County, Pennsylvania.

@en

P1433

Q35597413-493A08C4-7186-4A71-BA4E-9FF39C8DAC4C

P1476

Q35597413-BAF81D5A-AE5F-4934-8FA1-D24C2F9F8033

P2093

Q35597413-0719DB9C-6A0C-4FBA-AAD7-3E130ED91F33

Q35597413-A2633CCD-37C5-4227-9CBC-0CEE5AEC2713

Q35597413-BF04FE59-91C8-4FE5-99CE-8C1393631344

Q35597413-E4219A0C-49DB-445F-8125-21E5E75CF148

Q35597413-EF754AE1-AE14-4BE9-BDD4-5D318E979D13

P2860

Q35597413-01379612-AE90-4FDB-A47B-EBEDBC4D940D

Q35597413-17808499-3D2B-4EF2-B7C0-DAC506D7F347

Q35597413-2C2C20FF-D984-4AAB-9366-1C1D13485559

Q35597413-36E3E591-B387-4EA6-AF0F-13A9E0A076CC

Q35597413-3D3FB4EA-1F3D-4FD4-9A9C-38CA572D93B8

Q35597413-4053E141-7540-4BE7-9519-71FEA0A4B7DE

Q35597413-4B6FE478-B4DE-4E9E-81E6-C48551E2A2F2

Q35597413-4E4682D3-0EBF-45A9-A3A5-9747D9362AA7

Q35597413-53B8E280-3157-4C46-9B77-E580234499AE

Q35597413-5D817AB5-D831-4A8C-AF95-F30F100D35D0

P2888

Q35597413-12E08618-3FDA-4A33-A472-2632432430AC

P304

Q35597413-58306974-5BBD-46B7-A1C9-9ED05DA3C40A

P31

Q35597413-99B45F8E-FA68-41CF-AF20-535EE7D1224B

P356

Q35597413-6CC72792-68BA-44EA-8BF6-3AC7F39DE7AB

P433

Q35597413-AF3A9DA7-808B-4D66-9D0A-CAD11F1AC72E

P478

Q35597413-F2EFC6D6-AF76-479F-A89A-C287D75D7087

P577

Q35597413-7ECF0A39-A244-473D-BE9E-D65C5D4B35A8

P5875

Q35597413-73B5C189-8876-4EE5-BE4F-C47F55C6A918

P698

Q35597413-BA6A612C-2FA5-4CB5-A8B5-2AE6408453A7

P921

Q35597413-25AF98FB-C567-4C96-878E-07AC00DB6F62

P932

Q35597413-DA7DF48D-227F-4F33-A99B-0F5D9FB3CDEA

P356

S11524-011-9600-7

P1433

Journal of Urban Health

P1476

Characteristics of an overdose ...... llegheny County, Pennsylvania.

@en

P2093

Alex H Kral

http://www.w3.org/2001/XMLSchema#string

Alex S Bennett

http://www.w3.org/2001/XMLSchema#string

Alice Bell

http://www.w3.org/2001/XMLSchema#string

Eric G Hulsey

http://www.w3.org/2001/XMLSchema#string

Laura Tomedi

http://www.w3.org/2001/XMLSchema#string

P2860

Fatal heroin 'overdose': a review.

Overdose prevention and naloxone prescription for opioid users in San Francisco

Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City.

Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths.

Evaluation of a naloxone distribution and administration program in New York City.

Effective utilization and evaluation of indigenous health care workers.

Heroin overdose: research and evidence-based intervention.

Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States.

Providing naloxone to substance users for secondary administration to reduce overdose mortality in New York City

Secondary syringe exchange among injection drug users

P2888

s11524-011-9600-7

P304

1020-1030

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11524-011-9600-7

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51506524

http://www.w3.org/2001/XMLSchema#string

P698

21773877

http://www.w3.org/2001/XMLSchema#string

P921

P932

3232410

http://www.w3.org/2001/XMLSchema#string